Home LiteratureArticle Details
PMID: 10764427 Published · ppublish English Journal Article

Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence.

Park CC, Mitsumori M, Nixon A, Recht A, Connolly J, Gelman R, Silver B, Hetelekidis S, Abner A, Harris JR, Schnitt SJ

Abstract

To examine the relationship between pathologic margin status and outcome at 8 years after breast-conserving surgery and radiation therapy. The study population comprised 533 patients with International Union Against Cancer/American Joint Committee on Cancer clinical stage I or II breast cancer who had assessable margins, who received at least 60 Gy to the primary tumor bed, and who had more than 8 years of potential follow-up. Each margin was scored (according to the presence of invasive or in situ disease that touched the inked surgical margin) as one of the following: negative, close, focally positive, or extensively positive. Outcome at 8 years was calculated using crude rates of first site of failure. A polychotomous logistic regression analysis was performed. Median follow-up time was 127 months. At 8 years, patients with close margins and those with negative margins both had a rate of local recurrence (LR) of 7%. Patients with extensively positive margins had an LR rate of 27%, whereas patients with focally positive margins had an intermediate rate of LR of 14%. In the polychotomous logistic regression model, margin status and the use of systemic therapy were the only two variables that had significant effects on the risk ratio of LR to remaining alive and free of disease. Among the 45 patients with focally positive margins who received systemic therapy, the crude LR rate was 7% at 8 years (95% confidence interval, 1% to 20%). Pathologic margin status and the use of adjuvant systemic therapy are the most important factors associated with LR among patients treated with breast-conserving surgery and radiation therapy.

MeSH Terms
Adult Aged Aged, 80 and over Antineoplastic Agents/therapeutic use Breast Neoplasms/pathology,radiotherapy,therapy Carcinoma, Intraductal, Noninfiltrating/pathology,radiotherapy,therapy Combined Modality Therapy Female Follow-Up Studies Humans Logistic Models Mastectomy, Segmental Middle Aged Neoplasm Recurrence, Local Radiotherapy Dosage Retrospective Studies
Chemicals
Antineoplastic Agents
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Park C C
Joint Center for Radiation Therapy, Boston, MA 02215, USA. CPark@jcrt.harvard.edu
Mitsumori M
Nixon A
Recht A
Connolly J
Gelman R
Silver B
Hetelekidis S
Abner A
Harris J R
Schnitt S J
Article Info
Journal
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Abbr.
J Clin Oncol
ISSN
0732-183X
Published
2000-04-00
Pages
1668-75
Language
English
Region
United States
NLM ID
8309333
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com